Medplus Health Services Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹1,880Cr
- +21.8% YoY
- +0.9% QoQ
- Net profit
- ₹33Cr
- −21.4% YoY
- −48.4% QoQ
- Margin
- 7%
- −1 pp YoY
- −2 pp QoQ
Top 10 Retailing companies on management guidance
See the sector's top 10 — free with your mobile number.
What the Q1 FY27 call signalled
1 of 3 strong
The short version
MedPlus aims for a Same Store Sales Growth (SSSG) target of around 9%-10% for the full year FY27, though the Q1 reported SSSG was 15%. The company aims for a same-store sales growth (SSSG) target of around 9-10% for the full year FY27, with quarter 1 showing a strong 15% SSSG.
From Medplus Health Services Ltd's Q1 FY27 earnings-call transcript · updated 23 Sept 2026.
Revenue & Sales Performance
- MedPlus aims for a Same Store Sales Growth (SSSG) target of around 9%-10% for the full year FY27, though the Q1 reported SSSG was 15%. (page 19)
- Company expects volume growth driven by new store openings and better performance of existing stores. (page 19)
- Franchise store additions remain on track with guidance of 800 net store openings for FY27. (page 13)
- Revenue growth is expected to remain strong, with quarterly growth of 22% observed recently. (page 17)
- Management emphasizes stabilizing and increasing private label share, contributing to margin improvement and revenue recovery. (page 19)
- The company remains focused on contiguous state expansion rather than rapid pan-India expansion for the core pharmacy business. (page 17)
2 more points from Medplus Health Services Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Medplus Health Services Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company had approved capex plans including INR40 crores for a food park and oil extraction unit and another for a wellness services facility.
- These capex proposals have now been put on hold as of July 2026 after further deliberation and market feedback.
- Management emphasized that capex on the core business—warehousing and stores—has not stopped and will continue.
- Core business investments will continue.
- Wellness and concierge medicine-related expansion plans, initially considered, are unlikely to proceed for the moment.
2 more points from Medplus Health Services Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Retailing
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Medplus Health Services Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Medplus Health Services Ltd said on order book & pipeline — free account, 30 seconds.
Medplus Health Services Ltd — Quarterly revenue & net profit
Medplus Health Services Ltd Q1 FY27 results — key figures
| ₹ Cr | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 1,880 | 1,543 | +21.8% | 1,864 | +0.9% |
| Operating profit (EBITDA) | 133 | 131 | +1.5% | 169 | -21.3% |
| Operating margin | 7% | 8% | -1 pp | 9% | -2 pp |
| Profit before tax | 42 | 53 | -20.8% | 80 | -47.5% |
| Net profit (PAT) | 33 | 42 | -21.4% | 64 | -48.4% |
| EPS (₹) | 2.76 | 3.54 | -22% | 5.33 | -48.2% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.0K Cr, net profit ₹56 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Medplus Health's management said in earlier quarters
Others in Retailing this season
- Praxis Home (Q1 FY27)
Revenue from Operations for Q1 FY27: ₹2,660 Lakhs . Key investor presentation takeaways from Praxis Home's Q1 FY27 investor presentation — and how it ranks agai
- Intrasoft Technologies (Q1 FY27)
Revenue from Operations for the quarter: ₹13,963.30 lakhs, up from ₹12,899.12 lakhs in the previous year quarter, indicating a year-on-year increase. Key…
- Womancart (Q1 FY27)
If customer confidence grows, growth could be around 50%. Key concall takeaways from Womancart's Q1 FY27 earnings call — and how it ranks against sector peers.
- Bhatia Communications & Retail (India) (Q1 FY27)
190.67 crores . Key concall takeaways from Bhatia Communications & Retail (India) Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Retailing
on management's own guidance
- Strong growth2
- Strong growth1
- Lenskart SolutionsGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Medplus Health Services Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Medplus Health Services Ltd Q1 FY27 results?
MedPlus aims for a Same Store Sales Growth (SSSG) target of around 9%-10% for the full year FY27, though the Q1 reported SSSG was 15%. The company aims for a same-store sales growth (SSSG) target of around 9-10% for the full year FY27, with quarter 1 showing a strong 15% SSSG.
What is Medplus Health Services Ltd share price analysis?
Medplus Health Services Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 37.6 with a market cap of ₹7,925 Cr. Investors should review the full earnings analysis for detailed insights.
Is Medplus Health Services Ltd planning capital expenditure?
The company had approved capex plans including INR40 crores for a food park and oil extraction unit and another for a wellness services facility.
Keep Medplus Health Services Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
